- Home
- LGVN vs ADGM Comparison
LGVN vs ADGM Comparison
Compare LGVN & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- ADGM
- Stock Information
- Founded
- LGVN 2014
- ADGM 2011
- Country
- LGVN United States
- ADGM United States
- Employees
- LGVN N/A
- ADGM N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- ADGM
- Sector
- LGVN Health Care
- ADGM
- Exchange
- LGVN Nasdaq
- ADGM NYSE
- Market Cap
- LGVN 23.4M
- ADGM 19.7M
- IPO Year
- LGVN 2021
- ADGM N/A
- Fundamental
- Price
- LGVN $1.23
- ADGM $1.27
- Analyst Decision
- LGVN Strong Buy
- ADGM
- Analyst Count
- LGVN 3
- ADGM 0
- Target Price
- LGVN $8.67
- ADGM N/A
- AVG Volume (30 Days)
- LGVN 132.9K
- ADGM 68.2K
- Earning Date
- LGVN 05-08-2025
- ADGM 05-15-2025
- Dividend Yield
- LGVN N/A
- ADGM N/A
- EPS Growth
- LGVN N/A
- ADGM N/A
- EPS
- LGVN N/A
- ADGM N/A
- Revenue
- LGVN $2,225,000.00
- ADGM $576,000.00
- Revenue This Year
- LGVN N/A
- ADGM N/A
- Revenue Next Year
- LGVN $24.82
- ADGM N/A
- P/E Ratio
- LGVN N/A
- ADGM N/A
- Revenue Growth
- LGVN 127.50
- ADGM 116.54
- 52 Week Low
- LGVN $0.77
- ADGM $0.63
- 52 Week High
- LGVN $6.40
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- LGVN 39.93
- ADGM N/A
- Support Level
- LGVN $1.25
- ADGM N/A
- Resistance Level
- LGVN $1.37
- ADGM N/A
- Average True Range (ATR)
- LGVN 0.09
- ADGM 0.00
- MACD
- LGVN -0.01
- ADGM 0.00
- Stochastic Oscillator
- LGVN 30.00
- ADGM 0.00
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.